Evidence map›Paper›PMID 18186617›Full record

ArticleBiochemistry2008

Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.

Amy E Schmidt, Mao-fu Sun, Taketoshi Ogawa, S Paul Bajaj, David Gailani

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Amy E SchmidtUCLA/Orthopaedic Hospital, Department of Orthopaedic Surgery and Molecular Biology Institute, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Mao-fu Sun
Taketoshi Ogawa
S Paul Bajaj
David Gailani
Vanderbilt University · USOrthopaedic Hospital · US

Funding

Physiology and Molecular Biology of Factor XIR01HL058837 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GAILANI, DAVID · 1997 to 2017
$6.4M
BIOCHEMISTRY OF VARIANTS OF FACTOR IXR01HL036365 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BAJAJ, S PAUL · 1986 to 2011
$3.7M
Molecular Recognition in Factor VIIa Induced CoagulationR01HL070369 · NHLBI · SAINT LOUIS UNIVERSITY · PI BAJAJ, S PAUL · 2002 to 2005
$1.2M
Biochemistry of Normal and Abnormal Variants of Factor IXR56HL036365 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BAJAJ, S PAUL · 2007 to 2007
$356k
BIOCHEMISTRY OF NORMAL &ABNORMAL VARIANTS OF FACTOR IXR55HL036365 · NHLBI · SAINT LOUIS UNIVERSITY · PI BAJAJ, S PAUL · 1991 to 1991
–
NHLBI NIH HHS HL36365NHLBI NIH HHS HL58837NHLBI NIH HHS HL70369NHLBI NIH HHS R01 HL036365NHLBI NIH HHS R01 HL058837NHLBI NIH HHS R01 HL070369NHLBI NIH HHS R56 HL036365
6 · The paper itself

Abstract

In serine proteases, Gly193 (chymotrypsin numbering) is conserved with rare exception. Mutants of blood coagulation proteases have been reported with Glu, Ala, Arg or Val substitutions for Gly193. To further understand the role of Gly193 in protease activity, we replaced it with Ala or Val in coagulation factor XIa (FXIa). For comparison to the reported FXIa Glu193 mutant, we prepared FXIa with Asp (short side chain) or Lys (opposite charge) substitutions. Binding of p-aminobenzamidine (pAB) and diisopropylfluorphosphate (DFP) were impaired 1.6-36-fold and 35-478-fold, respectively, indicating distortion of, or altered accessibility to, the S1 and oxyanion-binding sites. Val or Asp substitutions caused the most impairment. Salt bridge formation between the amino terminus of the mature protease moiety at Ile16 and Asp194, essential for catalysis, was impaired 1.4-4-fold. Mutations reduced catalytic efficiency of tripeptide substrate hydrolysis 6-280-fold, with Val or Asp causing the most impairment. Further studies were directed toward macromolecular interactions with the FXIa mutants. kcat for factor IX activation was reduced 8-fold for Ala and 400-1100-fold for other mutants, while binding of the inhibitors antithrombin and amyloid beta-precursor protein Kunitz domain (APPI) was impaired 13-2300-fold and 22-27000-fold, respectively. The data indicate that beta-branching of the side chain of residue 193 is deleterious for interactions with pAB, DFP and amidolytic substrates, situations where no S2'-P2' interactions are involved. When an S2'-P2' interaction is involved (factor IX, antithrombin, APPI), beta-branching and increased side chain length are detrimental. Molecular models indicate that the mutants have impaired S2' binding sites and that beta-branching causes steric conflicts with the FXIa 140-loop, which could perturb the local tertiary structure of the protease domain. In conclusion, enzyme activity is impaired in FXIa when Gly193 is replaced by a non-Gly residue, and residues with side chains that branch at the beta-carbon have the greatest effect on catalysis and binding of substrates.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAmyloid beta-Protein PrecursorAntithrombinsBenzamidinesCarbamatesFactor IXFactor XIaHumansIsoflurophateKineticsModels, Molecular4-aminobenzamidineAmyloid beta-Protein PrecursorAntithrombinsBenzamidinesCarbamatesFactor IXFactor XIaIsoflurophate

Identifiers

PMID18186617
PMCPMC2885443
OpenAlexW1976627920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.